Floatz logo

236 assets in Ovarian Carcinoma

Therapeutic assets addressing Ovarian Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pasifolate Exatecan
Ovarian Carcinoma
Elucida OncologyP1/2CC (45)
Pep-Dc1
Ovarian Carcinoma
Centre Hospitalier Universitaire VaudoisP1/2CC (45)
Pep-Dc2
Ovarian Carcinoma
Centre Hospitalier Universitaire VaudoisP1/2CC (45)
Tegavivint
Ovarian Carcinoma
Children's Oncology GroupP1/2CC (45)
[18F]FPyQCP
Ovarian Carcinoma
Blue Earth DiagnosticsP1/2CC (43)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Ovarian Carcinoma
Nurix Therapeutics, Inc.P1CC (43)
23me-00610
Ovarian Carcinoma
23andMe, Inc.P1/2CC (43)
ab-1015
Ovarian Carcinoma
Arsenal Biosciences, Inc.P1CC (43)
Abbv-400
Ovarian Carcinoma
AbbVieP1CC (43)
Autologous Muc1-Activated T-Cells
Ovarian Carcinoma
Mayo ClinicP1CC (43)
Avzo-021
Ovarian Carcinoma
Avenzo Therapeutics, Inc.P1/2CC (43)
Bendamustine
Ovarian Carcinoma
Mayo ClinicP1CC (43)
Bet Bromodomain Inhibitor Zen-3694
Ovarian Carcinoma
National Cancer Institute (NCI)P1CC (43)
bp1001-a
Ovarian Carcinoma
Bio-Path Holdings, Inc.P1CC (43)
Claudin 18.2 Car-T
Ovarian Carcinoma
Suzhou Immunofoco Biotechnology Co., LtdP1CC (43)
Dual-Target Car-Nk Cell Product
Ovarian Carcinoma
Beijing BiotechP1/2CC (43)
e7777
Ovarian Carcinoma
Alexander B Olawaiye, MDP1/2CC (43)
Eb-Dualnk
Ovarian Carcinoma
Beijing BiotechP1/2CC (43)
Elimusertib
Ovarian Carcinoma
National Cancer Institute (NCI)P1CC (43)
Etx-19477
Ovarian Carcinoma
858 Therapeutics, Inc.P1/2CC (43)
Fluorthanatrace F-18
Ovarian Carcinoma
Abramson Cancer Center at Penn MedicineP1CC (43)
Immunoglobulin G1 [188,412-Bis[4-(Azidomethyl)-L-Phenylalanine]], Anti-(Human Folate Receptor ?) (Human-Mus Musculus Monoclonal Sp8166 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Sp8166 ?-Chain, Dimer, Click Reaction Product With 3-[[[[4-[[N-[4-(11,12-Didehydrodibenz[B,F]Azocin-5(6H)-Yl)-1,4-Dioxobutyl]-L-Valyl-N5-(Aminocarbonyl)-L-Ornithyl]Amino]Phenyl]Methoxy]Carbonyl]Amino]-N,?,?-Trimethyl-L-Phenylalanyl-N-[(1S,2E)-3-Carboxy-1-(1-Methylethyl)-2-Buten-1-Yl]-N,3-Dimethyl-L-Valinamide (1:4)
Ovarian Carcinoma
Sutro Biopharma, Inc.P1CC (43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Ovarian Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Ovarian Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Innocell Autologous Cellular Immunotherapy
Ovarian Carcinoma
PhotonPharma, Inc.P1CC (43)
jk08
Ovarian Carcinoma
Salubris Biotherapeutics IncP1/2CC (43)
kfa115
Ovarian Carcinoma
Novartis PharmaceuticalsP1CC (43)
lyl797
Ovarian Carcinoma
Lyell Immunopharma, Inc.P1CC (43)
Muamycin
Ovarian Carcinoma
City of Hope Medical CenterP1CC (43)
Oatd-02
Ovarian Carcinoma
Molecure S.A.P1CC (43)
Pelcitoclax
Ovarian Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pradusinstobart
Ovarian Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Prgn-3005 Ultracar-T Cells
Ovarian Carcinoma
Precigen, IncP1CC (43)
Tuvusertib
Ovarian Carcinoma
National Cancer Institute (NCI)P1CC (43)
Xp-Dc Vaccine
Ovarian Carcinoma
Radboud University Medical CenterP1/2CC (43)
Lorigerlimab
Ovarian Carcinoma
MacroGenicsP1CC (42)
Mirvetuximab
Ovarian Carcinoma
Shattuck Labs, Inc.P1CC (42)
sl-172154
Ovarian Carcinoma
Shattuck Labs, Inc.P1CC (42)
Amt-151
Ovarian Carcinoma
Multitude Therapeutics Inc.P1CC (41)
Atv-1601
Ovarian Carcinoma
Atavistik Bio, IncP1CC (41)
Ava-6000 (Fap-Activated Doxorubicin Prodrug)
Ovarian Carcinoma
Avacta Life Sciences LtdP1CC (41)
Certepetide
Ovarian Carcinoma
University of California, San DiegoP1CC (41)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Carcinoma
Dana-Farber Cancer InstituteP1CC (41)
dt2216
Ovarian Carcinoma
Elizabeth Stover, MD, PhDP1CC (41)
Fludeoxyglucose
Ovarian Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (41)
Genetically Engineered Ny-Eso-1-Specific T Lymphocytes
Ovarian Carcinoma
Roswell Park Cancer InstituteP1CC (41)
nkt3447
Ovarian Carcinoma
NiKang Therapeutics, Inc.P1CC (41)
nkt3964
Ovarian Carcinoma
NiKang Therapeutics, Inc.P1CC (41)
nm32-2668
Ovarian Carcinoma
Numab Therapeutics AGP1CC (41)
pf-07820435
Ovarian Carcinoma
PfizerP1CC (41)
Showing 151 to 200 of 236 assets
PreviousPage 4 of 5Next